PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1164907
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1164907
Drug Discovery Outsourcing Market with COVID-19 Impact Analysis, By Type, By Drug Type, Therapeutic Area, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2022-2028
REPORT HIGHLIGHT
The Drug Discovery Outsourcing Market size was valued at USD 3,407.1 Million in 2021, expanding at a CAGR of 7.8% from 2022 to 2028.
Drug discovery outsourcing is the process of discovering new drugs or medicines in sectors such as pharmacology, biotechnology, and pharmaceuticals. Drug discovery is a time-consuming procedure, with an extremely low success rate. Various new and small industry players create pharmaceuticals and sell them to the big players so that they can study the results of the trials and determine whether the drugs are useful or not.
Market Dynamics:
Due to companies interacting more and leveraging expertise, it is projected that the market for outsourcing drug discovery would expand. To exploit any proprietary technology, chemicals, and other resources, organizations are forming new strategic partnerships with multiple academic institutions, venture capitalists for finance, and other private or public firms. Growing collaborations between public and private entities have sped up drug discovery, increasing demand for outsourcing drug discovery globally. For instance, in June 2017, Eisai extended its partnership with Charles River Laboratories International, Inc., an early-stage CRO, to discover novel treatments for neurological and tropical diseases. Thus, such collaborations spur the need for identifying better drug candidates, propelling industry development.
The rising incidence rate of metabolic, genetic, and other chronic diseases is expected to provide a lucrative opportunity for market growth. Numerous diseases, including diabetes, cancer, malaria, cardiology, cystic fibrosis, multiple sclerosis, and many more, are currently affecting large numbers of people, necessitating the use of cutting-edge medications. For instance, as per the World Health Organization, more than 11 million people suffered from tuberculosis, which is accounted for around 1.4 million deaths. The number of patients with diabetes is anticipated to increase to 350 million by 2027 due to improper diet, a rising obese population, an aging population, coupled with an inactive lifestyle.
COVID-19 Impact:
The COVID-19 virus is now a significant public health issue. Pharmaceutical businesses have come to the forefront of this crisis and have gained widespread notice. The importance of medication development and discovery has been illustrated by the COVID-19 pandemic. Outsourcing drug research has become essential to creating virus-fighting drugs that work. Exscientia provided proof-of-concept in July 2021 by utilizing its AI platform to create a novel family of inhibitors that target Mpro, also known as 3CLpro, the primary protease enzyme of the COVID-19-causing SARS-CoV-2. By moving the first three entirely AI-designed small molecule therapeutic candidates into clinical trials, Exscientia has established a track record for enhancing and speeding drug discovery. Exscientia has formed partnerships with major pharmaceutical corporations such as Bristol-Myers Squibb, Bayer, Sanofi, and Dainippon Sumitomo, as well as other biotech firms. Thus, COVID-19 will have a significant impact on the global market for Drug Discovery Outsourcing, as the future of many medications under development is dependent on the outcomes of numerous current studies.
Geography Insights:
North America was the market leader in 2021 and is expected to expand throughout the projected period. The regional market's expansion can be attributed to technical improvements, the presence of well-established research infrastructure and significant companies, and increased investments in drug discovery R&D. Outsourcing is no longer only about cutting costs; increased demands for efficiency, quality, and innovation are likely to drive industry growth. During the forecast period, the Asia region is expected to have the quickest CAGR. Because of the availability of competent labor, cheaper costs, a favorable regulatory framework, and high-quality data, the region is emerging as a hub for outsourcing drug discovery activities.
Recent Development:
In April 2019, Eurofins Discovery Services, a contract research business, introduced DiscoveryOne, a new drug discovery service. The novel technique is beneficial to drug discovery research and preclinical development.
Key features of the study:
This proposed research study on the Drug Discovery Outsourcing market provides market size (US$ Million), compound annual growth rate (CAGR %) and forecast estimation (2022-2028), considering 2021 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for the Drug Discovery Outsourcing market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain the Drug Discovery Outsourcing market
The impact of COVID-19 on the Drug Discovery Outsourcing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Drug Discovery Outsourcing market post-COVID will also be covered.
To give the users of this report a comprehensive view of the Drug Discovery Outsourcing market, we have also included a competitive landscape and key innovator analysis for the Drug Discovery Outsourcing market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Drug Discovery Outsourcing market.
In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.
The global Drug Discovery Outsourcing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DRUG DISCOVERY OUTSOURCING MARKET KEY PLAYERS
GenScript Biotech Corporation
Charles River Laboratories International, Inc.
Curia Inc.
Dalton Pharma Services
Evotec SE
PPD, Inc.
Oncodesign
Jubilant Life Sciences Limited
Eurofins Scientific
WuXi AppTec
Laboratory Corporation of America Holdings
GLOBAL DRUG DISCOVERY OUTSOURCING MARKET, BY TYPE
Medical Chemistry Service
Biology Service
GLOBAL DRUG DISCOVERY OUTSOURCING MARKET, BY DRUG TYPE
Small Molecule
Large Molecules (Biopharmaceuticals)
GLOBAL DRUG DISCOVERY OUTSOURCING MARKET, BY THERAPEUTIC AREA
Oncology
Infectious Disease
Respiratory Disease
Cardiovascular
Gastrointestinal
Others
GLOBAL DRUG DISCOVERY OUTSOURCING MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
TABLE OF CONTENT
1. Drug Discovery Outsourcing Market Overview
- 1.1. Study Scope
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Market Snippet by Type
- 2.1.2. Market Snippet by Drug Type
- 2.1.3. Market Snippet by Therapeutic Area
- 2.1.4. Market Snippet by Region
- 2.2. Competitive Insights
3. Drug Discovery Outsourcing Key Market Trends
- 3.1. Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Future Trends
4. Drug Discovery Outsourcing Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Drug Discovery Outsourcing Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Drug Discovery Outsourcing Market Landscape
- 6.1. Market Share Analysis, 2021
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Drug Discovery Outsourcing Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2021 & 2028 (%)
- 7.1.2. Medical Chemistry Service
- 7.1.3. Biology Service
8. Drug Discovery Outsourcing Market - By Drug Type
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Drug Type, 2021 & 2028 (%)
- 8.1.2. Small Molecule
- 8.1.3. Large Molecules (Biopharmaceuticals)
9. Drug Discovery Outsourcing Market - By Therapeutic Area
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Therapeutic Area, 2021 & 2028 (%)
- 9.1.2. Oncology
- 9.1.3. Infectious Disease
- 9.1.4. Respiratory Disease
- 9.1.5. Cardiovascular
- 9.1.6. Gastrointestinal
- 9.1.7. Others
10. Drug Discovery Outsourcing Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2021 & 2028 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
11. Key Vendor Analysis
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. GenScript Biotech Corporation
- 11.2.2. Charles River Laboratories International, Inc.
- 11.2.3. Curia Inc.
- 11.2.4. Dalton Pharma Services
- 11.2.5. Evotec SE
- 11.2.6. PPD, Inc.
- 11.2.7. Oncodesign
- 11.2.8. Jubilant Life Sciences Limited
- 11.2.9. Eurofins Scientific
- 11.2.10. WuXi AppTec
- 11.2.11. Laboratory Corporation of America Holdings
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Drug Discovery Outsourcing Market: Type Snapshot (2021)
- TABLE Segment Dashboard; Definition and Scope, by Type
- TABLE Global Drug Discovery Outsourcing Market, by Type 2017-2028 (USD Million)
- TABLE Drug Discovery Outsourcing Market: Drug Type Snapshot (2021)
- TABLE Segment Dashboard; Definition and Scope, by Drug Type
- TABLE Global Drug Discovery Outsourcing Market, by Drug Type 2017-2028 (USD Million)
- TABLE Drug Discovery Outsourcing Market: Therapeutic Area Snapshot (2021)
- TABLE Segment Dashboard; Definition and Scope, by Therapeutic Area
- TABLE Global Drug Discovery Outsourcing Market, by Therapeutic Area 2017-2028 (USD Million)
- TABLE Drug Discovery Outsourcing Market: Regional snapshot (2021)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Drug Discovery Outsourcing Market, by Region 2017-2028 (USD Million)
- TABLE North America Drug Discovery Outsourcing Market, by Country, 2017-2028 (USD Million)
- TABLE North America Drug Discovery Outsourcing Market, by Type, 2017-2028 (USD Million)
- TABLE North America Drug Discovery Outsourcing Market, by Drug Type, 2017-2028 (USD Million)
- TABLE North America Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2028 (USD Million)
- TABLE Europe Drug Discovery Outsourcing Market, by Country, 2017-2028 (USD Million)
- TABLE Europe Drug Discovery Outsourcing Market, by Type, 2017-2028 (USD Million)
- TABLE EuropeDrug Discovery Outsourcing Market, by Drug Type, 2017-2028 (USD Million)
- TABLE Europe Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2028 (USD Million)
- TABLE Asia Pacific Drug Discovery Outsourcing Market, by Country, 2017-2028 (USD Million)
- TABLE Asia Pacific Drug Discovery Outsourcing Market, by Type, 2017-2028 (USD Million)
- TABLE Asia Pacific Drug Discovery Outsourcing Market, by Drug Type, 2017-2028 (USD Million)
- TABLE Asia Pacific Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2028 (USD Million)
- TABLE Latin America Drug Discovery Outsourcing Market, by Country, 2017-2028 (USD Million)
- TABLE Latin America Drug Discovery Outsourcing Market, by Type, 2017-2028 (USD Million)
- TABLE Latin America Drug Discovery Outsourcing Market, by Drug Type, 2017-2028 (USD Million)
- TABLE Latin America Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2028 (USD Million)
- TABLE Middle East and Africa Drug Discovery Outsourcing Market, by Country, 2017-2028 (USD Million)
- TABLE Middle East and Africa Drug Discovery Outsourcing Market, by Type, 2017-2028 (USD Million)
- TABLE Middle East and Africa Drug Discovery Outsourcing Market, by Drug Type, 2017-2028 (USD Million)
- TABLE Middle East and Africa Drug Discovery Outsourcing Market, by Therapeutic Area, 2017-2028 (USD Million)
List of Figures
- FIGURE Drug Discovery Outsourcing Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2021
- FIGURE Type segment market share analysis, 2021 & 2028
- FIGURE Type segment market size forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Drug Type segment market share analysis, 2021 & 2028
- FIGURE Drug Type segment market size forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Therapeutic Area segment market share analysis, 2021 & 2028
- FIGURE Therapeutic Area segment market size forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Regional segment market share analysis, 2021 & 2028
- FIGURE Regional segment market size forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE North America Drug Discovery Outsourcing Market share and leading players, 2021
- FIGURE Europe Drug Discovery Outsourcing Market share and leading players, 2021
- FIGURE Asia Pacific Drug Discovery Outsourcing Market share and leading players, 2021
- FIGURE Latin America Drug Discovery Outsourcing Market share and leading players, 2021
- FIGURE Middle East and Africa Drug Discovery Outsourcing Market share and leading players, 2021
- FIGURE North America market share analysis by country, 2021
- FIGURE U.S. Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Canada Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Europe Drug Discovery Outsourcing Market share analysis by country, 2021
- FIGURE Germany Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Spain Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Italy Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE France Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE UK Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Russia Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Netherlands Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Sweden Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Poland Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Rest of the Europe Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Asia Pacific Drug Discovery Outsourcing Market share analysis by country, 2021
- FIGURE India Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE China Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Japan Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE South Korea Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Australia Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Thailand Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Indonesia Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Phillipines Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Rest of APAC Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Latin America Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Latin America Drug Discovery Outsourcing Market share analysis by country, 2021
- FIGURE Brazil Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Mexico Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Argentina Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Colombia Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Rest of LATAM Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Middle East and Africa Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Middle East and Africa Drug Discovery Outsourcing Market share analysis by country, 2021
- FIGURE Saudi Arabia Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE United Arab Emirates Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Israel Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Turkey Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Algeria Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Egypt Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
- FIGURE Rest of MEA Drug Discovery Outsourcing Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
